R & D

Advanced research instrumentation specialists Oxford Optronix to showcase solutions at The Genes & Cancer Meeting in Cambridge,

Abingdon, UK, 17th March 2015 – Oxford Optronix, the leading provider of advanced research instrumentation for the clinical medicine and life science industries, today announces that it will be showcasing its full range of cancer research solutions at The Genes & Cancer Annual Meeting at Robinson College, Cambridge, UK, from 13 - 15 April 2015.

Oxford Optronix will be exhibiting throughout the two-day event, which is now in its 31st year and is the longest-running cancer research meeting in the UK. The Oxford Optronix team will demonstrate its full range of advanced instrumentation products, including the next-generation OxyLite™ dissolved oxygen (pO2) and temperature monitors, the GelCount™ colony counter platform for cancer biologists and its recently launched HypoxyLab™ hypoxia workstation.

Advancing the frontiers of cancer research

Abingdon, UK, 23rd April 2014 – Oxford Optronix, the leading provider of advanced research instrumentation for the clinical medicine and life science industries, today releases a new whitepaper outlining the potential of automated colony counting and imaging systems for making major advances in cancer research.

“Advancing the frontiers of cancer research: automated colony counting for cancer biologists” is freely available for download now from the Oxford Optronix website: http://www.optronix1.com/white-paper/

In the wake of recent landmark discoveries into the molecular and biological changes underlying cancer development, laboratories are attempting to manage “industrial scale” research alongside increasingly restrained budgets from public and private funding bodies. The emergence of three dimensional arrays have only added to these pressures, as manually colony counting these complex in vitro culture systems is proving too labour intensive for laboratories to handle.

Advanced research instrumentation pioneer Oxford Optronix launches HypoxyLab™ – the industry’s first benchtop, HEPA-filtered hyp

Abingdon, UK, 12th November 2013. – Oxford Optronix, the leading provider of advanced
research instrumentation for the clinical medicine and life science industries, today announces the
formal launch of HypoxyLab™ – the industry’s first benchtop, HEPA-filtered,
precision-controlled hypoxia workstation. HypoxyLab creates optimal, contamination-free conditions
for a wide variety of cell-based research fields, including cancer biology, radiation cell biology,
cardiovascular research, apoptosis, neurology, stem cell research, multidisciplinary drug
development and proteomics.

HypoxyLab is a unique, fully-featured and easy-to-use hypoxia workstation that accurately reproduces
physiological conditions for cell-based research. HypoxyLab provides a highly stable, localised
environment in which levels of oxygen, carbon dioxide, temperature and humidity are precisely
controlled within a HEPA-filtered isolation work chamber.

Subscribe to RSS - R & D